Roth Capital has revised its price target for MaxLinear (MXL, Financial), reducing it from $21 to $11, while maintaining a Neutral rating on the stock. This adjustment follows the company's recent report, which showed revenues aligning closely with market expectations, indicating a steady recovery in broadband and connectivity orders.
Although MaxLinear is anticipated to regain operating profitability in the upcoming quarter, analysts express caution due to the ongoing uncertainties related to tariffs. These external factors continue to cloud the outlook, prompting a conservative stance despite improvements in the firm's operational performance.
